Virstatin inhibits dimerization of the transcriptional activator ToxT
- 13 February 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 104 (7), 2372-2377
- https://doi.org/10.1073/pnas.0611643104
Abstract
The development of antimicrobials is critical in this time of increasing antibiotic resistance of most clinically relevant bacteria. To date, all current antibiotics focus on inhibiting crucial enzymatic activities of their protein targets (i.e., trimethoprim for dihydrofolate reductase), thus disrupting in vitro essential gene functions. In contrast, we have previously reported the identification of virstatin, a small molecule that inhibits virulence regulation in Vibrio cholerae, thereby preventing intestinal colonization in an infant mouse model for cholera. Virstatin prevents expression of the two major V. cholerae virulence factors, cholera toxin (CT) and the toxin coregulated pilus, by inhibiting the virulence transcriptional activator ToxT. It has previously been described that the N-terminal domain of ToxT has the ability to form homodimers. We now demonstrate that virstatin inhibits ToxT dimerization, thus demonstrating that it further falls into a unique class of inhibitors that works by disrupting protein-protein interactions, particularly homodimerization. Using virstatin, truncation mutants of ToxT, and a virstatin-resistant mutant, we show that dimerization is required for ToxT activation of the ctx promoter. In contrast, ToxT dimerization does not appear to be required at all of the other ToxT-regulated promoters, suggesting multiple mechanisms may exist for its transcriptional activity.Keywords
This publication has 28 references indexed in Scilit:
- A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatisProceedings of the National Academy of Sciences of the United States of America, 2006
- The toxbox: specific DNA sequence requirements for activation of Vibrio cholerae virulence genes by ToxTMolecular Microbiology, 2006
- Protein–protein interactions as targets for small molecule drug discoveryPeptide Science, 2006
- Vibrio cholerae ToxT Independently Activates the Divergently Transcribed aldA and tagA GenesJournal of Bacteriology, 2005
- Small-Molecule Inhibitor of Vibrio cholerae Virulence and Intestinal ColonizationScience, 2005
- Small-Molecule Inhibitors Specifically Targeting Type III SecretionInfection and Immunity, 2005
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- Mechanism of ToxT-Dependent Transcriptional Activation at theVibrio cholerae tcpAPromoterJournal of Bacteriology, 2002
- Inhibition of Protein−Protein Association by Small Molecules: Approaches and ProgressJournal of Medicinal Chemistry, 2002
- Positive selection vectors for allelic exchangeGene, 1996